| Helicobacter pylori infection and the risk of gastric carcinoma J Parsonnet, GD Friedman, DP Vandersteen, Y Chang, JH Vogelman, ... New England Journal of Medicine 325 (16), 1127-1131, 1991 | 5229 | 1991 |
| Helicobacter pylori infection and gastric lymphoma J Parsonnet, S Hansen, L Rodriguez, AB Gelb, RA Warnke, E Jellum, ... New England Journal of Medicine 330 (18), 1267-1271, 1994 | 2489 | 1994 |
| The epidemiology of tuberculosis in San Francisco--a population-based study using conventional and molecular methods PM Small, PC Hopewell, SP Singh, A Paz, J Parsonnet, DC Ruston, ... New England Journal of Medicine 330 (24), 1703-1709, 1994 | 1580 | 1994 |
| Helicobacter pylori Virulence and Genetic Geography A Covacci, JL Telford, GD Giudice, J Parsonnet, R Rappuoli Science 284 (5418), 1328-1333, 1999 | 1442 | 1999 |
| Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. J Parsonnet, GD Friedman, N Orentreich, H Vogelman Gut 40 (3), 297-301, 1997 | 1262 | 1997 |
| Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts Helicobacter and Cancer Collaborative Group Gut 49 (3), 347-353, 2001 | 1201 | 2001 |
| Helicobacter pylori in peptic ulcer disease. NIH Consensus Jama 272, 65-69, 1994 | 710* | 1994 |
| The incidence of Helicobacter pylori infection. J Parsonnet Alimentary pharmacology & therapeutics 9, 45-51, 1995 | 593 | 1995 |
| Fecal and oral shedding of Helicobacter pylori from healthy infected adults J Parsonnet, H Shmuely, T Haggerty Jama 282 (23), 2240-2245, 1999 | 532 | 1999 |
| Helicobacter pylori Infection in Intestinal- and Diffuse-Type Gastric Adenocarcinomas J Parsonnet, D Vandersteen, J Goates, RK Sibley, J Pritikin, Y Chang JNCI: Journal of the National Cancer Institute 83 (9), 640-643, 1991 | 507 | 1991 |
| Parasitism by the MJ Blaser, J Parsonnet The Journal of clinical investigation 94 (1), 4-8, 1994 | 503 | 1994 |
| Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists J Parsonnet, MJ Blaser, GI Perez-Perez, N Hargrett-Bean, RV Tauxe Gastroenterology 102 (1), 41-46, 1992 | 422 | 1992 |
| Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials J Parsonnet, RA Harris, HM Hack, DK Owens The Lancet 348 (9021), 150-154, 1996 | 414 | 1996 |
| Antimicrobial resistance incidence and risk factors among Helicobacter pylori–infected persons, United States WM Duck, J Sobel, JM Pruckler, Q Song, D Swerdlow, C Friedman, ... Emerging infectious diseases 10 (6), 1088, 2004 | 347 | 2004 |
| Helicobacter pylori and gastric adenocarcinoma V Herrera, J Parsonnet Clinical Microbiology and Infection 15 (11), 971-976, 2009 | 340 | 2009 |
| Helicobacter pylori and gastric cancer J Parsonnet Gastroenterology Clinics of North America 22 (1), 89-104, 1993 | 338 | 1993 |
| Gastrin and colorectal cancer: a prospective study CM Thorburn, GD Friedman, CJ Dickinson, JH Vogelman, N Orentreich, ... Gastroenterology 115 (2), 275-280, 1998 | 332 | 1998 |
| Vitamin D deficiency and tuberculosis progression N Talat, S Perry, J Parsonnet, G Dawood, R Hussain Emerging infectious diseases 16 (5), 853, 2010 | 318 | 2010 |
| Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study S Anand, M Montez-Rath, J Han, J Bozeman, R Kerschmann, P Beyer, ... The Lancet 396 (10259), 1335-1344, 2020 | 315 | 2020 |
| Bacterial infection as a cause of cancer. J Parsonnet Environmental health perspectives 103 (suppl 8), 263-268, 1995 | 310 | 1995 |
Catherine LeyStanford University School of MedicineVerified email at stanford.edu
